Analystreport

Obalon Therapeutics Inc (NASDAQ: OBLN) had its "buy" rating re-affirmed by analysts at BTIG Research.

OBALON THERAPEUTICS  (OBLN) 
Last obalon therapeutics earnings: 11/8 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investor.obalon.com